Papillary Thyroid Cancer and Cutaneous Melanoma: An Often Underrecognized Pair
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Lazzara D, Zarkhin S, Rubenstein S, Glick B
. Melanoma and Thyroid Carcinoma: Our Current Understanding. J Clin Aesthet Dermatol. 2019; 12(9):39-41.
PMC: 6777696.
View
2.
Reusser N, Holcomb M, Krishnan B, Rosen T, Orengo I
. Cutaneous metastasis of papillary thyroid carcinoma to the neck: a case report and review of the literature. Dermatol Online J. 2015; 21(2).
View
3.
Mitchell B, Leone D, Feller J, Yang S, Mahalingam M
. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?. Hum Pathol. 2016; 52:19-27.
DOI: 10.1016/j.humpath.2015.12.030.
View
4.
Chen D, Su X, Zhu L, Jia H, Han B, Chen H
. Papillary thyroid cancer organoids harboring BRAF mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies. J Transl Med. 2023; 21(1):9.
PMC: 9827684.
DOI: 10.1186/s12967-022-03848-z.
View
5.
Oakley G, Curtin K, Layfield L, Jarboe E, Buchmann L, Hunt J
. Increased melanoma risk in individuals with papillary thyroid carcinoma. JAMA Otolaryngol Head Neck Surg. 2014; 140(5):423-7.
DOI: 10.1001/jamaoto.2014.78.
View